Hepatitis A virus surface antigens — Drug Target

5 drugs 4 marketed 1 in Phase 3

All drugs that target Hepatitis A virus surface antigens — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

inactivated viral vaccine · Inactivated viral vaccine

Marketed (4)

Phase 3 pipeline (1)